NCT01665300
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +7 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Clinical trial condition
Cardiotoxicity
Explore clinical trials studying Cardiotoxicity. Study availability and eligibility vary by location and protocol.
160 public trials
42 recruiting studies
Cardiotoxicity trial results
NCT02053974
- Conditions
- Anthracycline Induced Cardiotoxicity, Cardiotoxicity, Cardiovascular Diseases, +7 more
- Locations
-
- Erciyes University School of Medicine Kayseri, Turkey (Türkiye)
NCT00002827
- Conditions
- Cardiac Toxicity, Cardiotoxicity, Cardiovascular Diseases, +15 more
- Locations
-
- Long Beach Memorial Medical Center Long Beach, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
NCT01095926
- Conditions
- Acute Lymphoblastic Leukemia, Cardiotoxicity, Cardiovascular Diseases, +44 more
- Locations
-
- Centre Oscar Lambret Lille, France
- CHU La Timone Marseille, France
- MD Nicolas Andre, National Study Manager France Marseille, France
- CHU Nancy Nancy, France
NCT01230983
- Conditions
- Cardiac Toxicity, Cardiotoxicity, Cardiovascular Diseases, +17 more
- Locations
-
Not specified
NCT00636844
- Conditions
- Cancer, Cardiotoxicity, Cardiovascular Diseases, +8 more
- Locations
-
- George Washington University Washington D.C., District of Columbia, United States
NCT00039481
- Conditions
- Cardiac Toxicity, Cardiotoxicity, Cardiovascular Diseases, +8 more
- Locations
-
- Children's Oncology Group Arcadia, California, United States
Active, Not Recruiting
In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors
NCT06778122
- Conditions
- Cancer Survivors, Cardiotoxicity, Cardiovascular Diseases, +9 more
- Locations
-
- Gil y Morte Primary Care Practice Valencia, Spain
- Mallilla Primary Care Practice Valencia, Spain
- Russafa Primary Care Practice Valencia, Spain
Active, Not Recruiting
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
NCT04928261
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
Active, Not Recruiting
Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
NCT05271162
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +6 more
- Locations
-
- Institute of Hematology and Transfusion Medicine Warsaw, Poland
- National Institute of Oncology Warsaw, Poland